May 9, 2018
3,600


Eli Lilly & Co.'s antibody therapy was granted an emergency-use authorization by U.S. drug regulators for treating Covid-19, widening access to a treatment that early data suggests is effective in keeping people infected with the coronavirus out of the hospital.

The Food and Drug Administration authorized the treatment, called bamlanivimab, for use against mild-to-moderate Covid-19 in adult and pediatric patients, the agency said on its website.





 
Dec 31, 2017
7,633
Lmao. Just fyi, there is a method to the madness of naming these:

naming-antibody-antibodies-nomenclature-monoclonal-original.jpeg



Now we just need to figure out where the bamlan comes from.
 

Deleted member 2210

User-requested account closure
Banned
Oct 25, 2017
1,366
Why did I think of Black Betty with that name?

Ok that tweet did not load for me but yeah, I'm glad I'm not alone.
 
Oct 25, 2017
11,220
All these get brand names so it's not that weird. Half the things coming out these days are some manner of MCA with a -mab suffix.
 

Bebpo

Member
Feb 4, 2018
5,114
Are there any studies on if this one actually works? They've approved a lot that don't seem to so far.
 
Sep 14, 2019
3,186
With news of that vaccine and this, maybe we'll start starting seeing some improvements starting this summer, maybe?